Consistent with this finding, addition of testosterone (agonist of TRPM8 channel) or PYR-41 (inhibitor of ubiquitin-mediated degradation of TRPM8 protein) increased activity of TRPM8 in prostate cancer cells, leading to Ca2+ influx and apoptotic cell death [35]. This evidence concerns the gene TRPM8 and prostate carcinoma.